Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer

Autor: Bolis, Giorgio, Parazzini, Fabio, Scarfone, Giovanna, Villa, Antonella, Amoroso, Mariangela, Rabaiotti, Emanuela, Polatti, Anna, Reina, Simona, Pirletti, Elena
Zdroj: In Gynecologic Oncology January 1999 72(1):60-64
Databáze: ScienceDirect